Results 81 to 90 of about 12,958 (242)
Therapeutic Potentials of Psychedelic Drugs
, 2016 This article presents a brief look into the possible therapeutic Potentials of the psychedelic drugs LSD, psilocybin and DMT. It explores the theories of how these substances may have beneficial effects across the spectrum of pathologies from ...
Jesuthasan, Prathesh
core
The Psychedelic Experience: A New Perspective, a New Attitude Towards the World
This chapter provides a philosophical account of the potential of the psychedelic experience to treat depression. The main thesis is that such a potential lies in the possibility of psychedelics allowing us to experience a world diametrically opposed to ...
Ballesteros, Virginia
core +1 more source
Effects of DMT on mental health outcomes in healthy volunteers
Scientific ReportsPsilocybin, a serotonergic psychedelic, is being increasingly researched in clinical studies for the treatment of psychiatric disorders. The relatively lengthy duration of oral psilocybin’s acute effects (4–6 h) may have pragmatic and cost-effectiveness ...
Christopher Timmermann +4 more
doaj +1 more source
Preclinical models for evaluating psychedelics in the treatment of major depressive disorder
British Journal of Pharmacology, EarlyView.Psychedelic drugs have seen a resurgence in interest as a next generation of psychiatric medicines with potential as rapid‐acting antidepressants (RAADs). Despite promising early clinical trials, the mechanisms which underlie the effects of psychedelics are poorly understood.
Laith Alexander +5 more
wiley +1 more source
British Journal of Pharmacology, EarlyView.Abstract The past decade has seen a huge increase in clinical research with psychedelic drugs and 3,4‐methylenedioxymethamphetamine (MDMA), which have revealed great potential for treating mental health conditions. Given this progress in research, as well as the current unmet clinical need of millions of patients, in 2023, the Australian Therapeutic ...
David J Nutt +3 more
wiley +1 more source
Holistic approach to substance‐induced psychosis
Addiction, EarlyView.
Julia M. Lappin +2 more
wiley +1 more source
Psilocybin as a novel treatment for chronic pain
British Journal of Pharmacology, EarlyView.Abstract Psychedelic drugs are under active consideration for clinical use and have generated significant interest for their potential as anti‐nociceptive treatments for chronic pain, and for addressing conditions like depression, frequently co‐morbid with pain.
Tate Askey +3 more
wiley +1 more source
Psilocybin, a naturally occurring psychedelic compound found in certain fungi has long been used by Indigenous cultures within ritual and ceremony for healing and spiritual purposes (Spiers et al., 2024).
Rolleston, Anna +11 more
core +1 more source
From relaxed beliefs under psychedelics (REBUS) to revised beliefs after psychedelics (REBAS)
Scientific ReportsThe Relaxed Beliefs Under pSychedelics (REBUS) model proposes that serotonergic psychedelics decrease the precision weighting of neurobiologically-encoded beliefs.
Richard J. Zeifman +7 more
doaj +1 more source